Saturn V Capital Management LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Saturn V Capital Management LP disclosed 21 US equity positions worth $552.2m in its Q1 2026 13F filing. The largest position was ALMS at 12.8% of the reported book, followed by AMLX and ABVX.
What did Saturn V Capital Management LP own in Q1 2026? Top 21 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ALMS ALUMIS INC | Healthcare | 12.8% | $70.5m | 3,202,075 | – | |
| 2 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 10.9% | $60.5m | 4,349,885 | – | |
| 3 | ABVX ABIVAX SA | Healthcare | 10.9% | $60.4m | 542,696 | – | |
| 4 | PCVX VAXCYTE INC | Healthcare | 8.7% | $47.9m | 824,532 | – | |
| 5 | PHVS PHARVARIS N V | Healthcare | 6.1% | $33.9m | 1,201,402 | – | |
| 6 | IMMX IMMIX BIOPHARMA INC | 6.1% | $33.6m | 3,693,585 | – | ||
| 7 | CELC CELCUITY INC | Healthcare | 5.8% | $32.2m | 281,904 | – | |
| 8 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 5.6% | $30.8m | 162,961 | – | |
| 9 | IRON DISC MEDICINE INC | Healthcare | 5.2% | $28.8m | 449,926 | – | |
| 10 | XFOR X4 PHARMACEUTICALS INC | 4.8% | $26.7m | 6,456,646 | – | ||
| 11 | COGT COGENT BIOSCIENCES INC | Healthcare | 4.4% | $24.1m | 626,635 | – | |
| 12 | MNPR MONOPAR THERAPEUTICS INC | 3.4% | $18.9m | 345,626 | – | ||
| 13 | DYN DYNE THERAPEUTICS INC | Healthcare | 3.2% | $17.5m | 966,609 | – | |
| 14 | IVVD INVIVYD INC | Healthcare | 2.6% | $14.2m | 10,949,084 | – | |
| 15 | CADL CANDEL THERAPEUTICS INC | 2.6% | $14.2m | 2,896,588 | – | ||
| 16 | OCULIS HOLDING AG | 2.5% | $13.7m | 516,761 | – | ||
| 17 | OVID OVID THERAPEUTICS INC | Healthcare | 1.7% | $9.2m | 4,166,666 | – | |
| 18 | IKT INHIBIKASE THERAPEUTICS INC | 1.2% | $6.5m | 3,863,445 | – | ||
| 19 | ZURA ZURA BIO LTD | Healthcare | 0.8% | $4.4m | 739,960 | – | |
| 20 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.4% | $2.0m | 88,999 | – | |
| 21 | MSLE SATELLOS BIOSCIENCE INC | 0.4% | $2.0m | 350,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.